- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Reform Update: Medicare Managed Care Linked to Overall Savings, Study Finds
Hospital visits are shorter and less costly for all patients in markets with more of them enrolled in Medicare managed care, according to new research. The results suggest hospitals make far-reaching changes to delivery as incentives to better manage care increase.
Incentives to coordinate care prompt investments, such as information technology, and widespread adoption of new delivery models that ultimately benefit all patients, regardless of insurance, a trio of Harvard University researchers wrote in a paper published by the National Bureau of Economic Research.
Hospital costs for enrollees in traditional fee-for-service Medicare would drop by $600 million when the Medicare Advantage market share increases 5 percentage points of the market, according to an analysis of spending at the county level in five states.
Read the full story here: http://bit.ly/10EgPlF
Source: Modern Healthcare
Similar outcomes may be true for other Medicare models—including accountable care and bundled payments under health reform—that seek to incentivize greater care management as managed care does, said Katherine Baicker, a health economics professor at the Harvard School of Public Health, who co-authored the paper with Michael Chernew and Jacob Robbins.
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
